Aquatic environmental assessment of the top 25 English prescription pharmaceuticals

Water Research

Volumn 36, Issue 20, 2002, Pages 5013-5022

  Jones, O A H ^a   Voulvoulis, N ^a   Lester, J N ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aquatic environment; Aquatic toxicity; Fate; Modelling; Pharmaceuticals; Risk

Indexed keywords

DATA REDUCTION; DRUG PRODUCTS; ENVIRONMENTAL ENGINEERING; SEWAGE SLUDGE; TOXICITY;

TOXICITY DATA;

WATER ANALYSIS;

DRUG; MEFENAMIC ACID; OCTANOL; OXYTETRACYCLINE; PARACETAMOL; WATER;

AQUATIC ENVIRONMENT; ENVIRONMENTAL ASSESSMENT; PHARMACEUTICAL INDUSTRY; TOXICITY;

AQUATIC ENVIRONMENT; ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); ENVIRONMENTAL IMPACT ASSESSMENT; MODEL; PREDICTION; PRIORITY JOURNAL; SLUDGE; WATER ANALYSIS;

EID: 0036888039     PISSN: 00431354     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0043-1354(02)00227-0     Document Type: Article

References (43)

1. Jones O.A.H., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment. a review Environ Technol. 22:2001;1383-1395.
2. Ternes T. Pharmaceuticals and metabolites as contaminants of the aquatic environment. an overview J Amer Chem Soc. 219:2000;301-309.
3. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol. 37:1985;1-12.
4. Aherne G.W., Briggs R. The relevance of the presence of certain synthetic steroids in the aquatic environment. J Pharm Pharmacol. 41:1989;735-736.
5. Ayscough NJ, Fawell J, Franklin G, Young W. Review of human pharmaceuticals in the environment: technical report P390. Environmental Agency, Bristol, England, 2000.
6. Ternes T. Pharmaceuticals in rivers, groundwater and drinking water. In: Proceedings of the International Seminar on Pharmaceuticals in the Environment, Brussels Technological Institute, March 9, 2000.
7. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32:1998;3245-3260.
8. Ares ME. The Impacts of Low Levels of Antibiotics on Freshwater Microbial Communities. Ph.D. thesis, Imperial College, London, 1999.
9. Buser H.R., Poiger T., Muller M.D. Occurrence and environmental behaviour of the pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol. 33:1999;2529-2535.
10. Daughton C.G., Ternes T.A. Special report: pharmaceuticals and personal care products in the environment. agents of subtle change? Environ Health Perspect. 107:1999;907-938.
11. Meakins N.C., Bubb J.M., Lester J.N. The fate and behaviour of organic micropollutants during wastewater treatment processes. a review Int J Environ Pollut. 4:1994;27-58.
12. FDA 1995. Guidance for Industry for the Submission of an Environmental Assessment in Human Drug Applications and Supplements. Food and Drug Administration, Rockville, USA.
13. EU, 1994. Assessment of Potential Risks to the Environment Posed by Medicinal Products for Human Use, Excluding Products Containing Live Genetically Modified Organisms. EU Ad Hoc Working party, III/5504/94 Draft 4. European Commission, Brussels, Belgium.
14. Rodger J. Personal communication with Jim Rodger, Statistics Department 1E, UK. Department of Health, Richmond House, 79 Whitehall, London, SW1A 2NS, 2001.
15. Lai K.M., Johnson K.L., Scrimshaw M.D., Lester J.N. Binding of waterborne steroid Estrogens to solid phases in river and estuarine systems. Environ Sci Technol. 34:2000;3890-3894.
16. Lai K.M., Johnson K.L., Scrimshaw M.D., Lester J.N. Biotransformation and bioconcentration of steroid Estrogens by Chlorella vulgaris. Appl Environ Microbiol. 68:2002;859-864.
17. Lai K.M., Scrimshaw M.D., Lester J.N. Prediction of the bioaccumulation factors and body burden of natural and synthetic estrogens in aquatic organism in river systems. Sci Total Environ. 289:2002;159-168.
18. Lai K.M., Johnson K.L., Scrimshaw M.D., Lester J.N. The effects of natural and synthetic steroid Estrogens in relation to their environmental occurrence. Crit Rev Toxicol. 32:2002;113-132.
19. US Environmental Protection Agency, 1996. ECOTOX database program, version 1. US Environmental Protection Agency, Mid-Continent Ecology Division, Duluth, USA.
20. US Environmental Protection Agency, 2001. Estimation Program Interface EPI; Suite, Version 3.10. Environmental Protection Agency, Office of Pollution Prevention and Toxic's, Washington DC, USA.
21. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten-Lützhøft H.C., Halling-Sørensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere. 40:2000;783-793.
22. UK Office for National Statistics, 2001. Key population and vital statistics 2000. UK Office for National Statistics, Hampshire, UK.
23. Day M. Personal Communication with MartinDay, WRc plc, Frankland Road, Blagrove, Swindon, Wiltshire, SN5 8YF, UK, 2001.
24. Merck, 2001, The Merck Index, 13th Ed. London: Merck Publications.
25. Meylan W.M., Howard P.H., Boethling R.S. Improved method for estimating bioconcentration/bioaccumulation factors from the octanol/water partition coefficient. Environ Toxicol Chem. 18:1999;664-672.
26. Lyman W.J. Adsorption coefficient for soils and sediments. Lyman W.J., Reehl W.F., Rosenblatt D.H. Handbook of Chemical Property Estimation Methods. 1990;American Chemical Society, Washington, USA.
27. Sabljic A. On the prediction of soil sorption coefficients of organic pollutants from molecular structure. application of a molecular topology model Environ Sci Technol. 21:1987;358-366.
28. Meylan W.M., Howard P.H. Improved method for estimating water solubility from octanol/water partition coefficients. Environ Toxicol Chem. 15:1996;100-106.
29. Clark B., Henry J.G., Mackay D. Fugacity analysis and model of organic chemical fate in a sewage treatment plant. Environ Sci Technol. 29:1995;1488-1494.
30. Webb SF. Risk assessment approaches for pharmaceuticals. In: Proceedings of the International Seminar on Pharmaceuticals in the Environment, Brussels Technological Institute, March 9, 2000.
31. Holten-Lützhøft H.C., Halling-Sørensen B., Jørgensen H.E. Algal toxicity of antibacterial agents applied in Danish fish farming. Arch Environ Contam Toxicol. 36:1999;1-6.
32. Buser H.R., Poiger T., Muller M.D. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters. rapid photodegradation in a lake Environ Sci Technol. 32:1998;3449-3456.
33. Halling-Sørensen B., Nielsen N., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.S. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere. 36:1998;357-393.
34. CSTEE, 2001. Opinion on "Draft Discussion Paper on Environmental Risk Assessment of Non-Genetically Modified Organism non-gmo; Containing Medicinal Products for Human Use". European Commission, Directorate General, Brussels, Belgium.
35. Rand GM. Fundamentals of Aquatic Toxicology. Taylor & Francis Inc. London, 1995.
36. Larsson D.G.J., Asolfsson-Erici M., Parkkonen J., Petterson M., Berg A.H., Olsson P.E., Forlin L. Ethinyloestradiol - an undesired fish contraceptive? Aquat Toxicol. 45:1999;91-97.
37. 2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresenius J Anal Chem. 362:1998;329-340.
38. Halling-Sørensen B. Algal Toxicity of antibacterial agents used in intensive farming. Chemosphere. 40:2000;731-739.
39. Voulvoulis N., Scrimshaw M.D., Lester J.N. Alternative antifouling biocides. Appl Organomet Chem. 13:1999;135-143.
40. Raloff J. Drugged waters - Does it matter that pharmaceuticals are turning up in water supplies? Sci News. 153:1998;187-189.
41. Sacher F, Haist-Gulde B, Brauch HJ, Zullei-Seibert N, Preuss G, Meisenheimer M, Welsch H, Ternes TA. Behaviour of selected pharmaceuticals during drinking water treatment. Abstr Paper Am Chem Soc 219, 45-ENVR, 2000.
42. Lester JN, Birkett JW. Microbiology and Chemistry for Environmental Scientists and Engineers, 2nd Ed. London: E and FN Spon Ltd., 1999.
43. Environment Agency of England and Wales, 2000. State of the Environment Report, Thames Region, Section 2, Environmental Agency, Bristol, England.